SCENESSE® DNA REPAIR STUDY IN HEALTHY VOLUNTEERS APPROVED
Melbourne, Australia, 30 November 2020 CLINUVEL PHARMACEUTICALS LTD today announced that it...
Read More
Jefferies Virtual London Healthcare Conference Presentation
20 November 2020 Download presentation & speaker’s notes
Read More
Chair's Letter To Shareholders
19 November 2020 Dear fellow shareholder, I look back at a year...
Read More
Results of Annual General Meeting
In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations...
Read More
MANAGING DIRECTOR’S PRESENTATION TO CLINUVEL ANNUAL GENERAL MEETING
The following is a transcript of the Managing Director’s presentation to the...
Read More
CHAIR’S ADDRESS TO CLINUVEL ANNUAL GENERAL MEETING
I am up for re-election today, thank you for those who supported...
Read More
CLINUVEL Strategic Update – Executive Summary
CLINUVEL PHARMACEUTICALS LTD today released a strategic update on its business. An...
Read More
Further Research Coverage Initiated on CLINUVEL
CLINUVEL PHARMACEUTICALS LTD today informed its shareholders and interested investors that Jefferies...
Read More
CLINUVEL Annual General Meeting 2020
CLINUVEL PHARMACEUTICALS LTD’s 2020 Annual General Meeting (AGM) will be held on...
Read More
SCIENTIFIC COMMUNIQUÉ VI
Ultraviolet Radiation Damage and Oxidative Stress in Skin Cancer. October 2020 Introduction...
Read More
CLINUVEL News & Facts site live
Earlier this week CLINUVEL launched a new microsite, CLINUVEL News & Facts. The CLINUVEL...
Read More
Kommuniqué V, 20-23 September 2020
Liebe Aktionäre, Freunde, Während die Welt darum kämpft, die Verbreitung von...
Read More
CLINUVEL Newsletter V
Dear shareholders, friends, As the world battles on to control the...
Read More